Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05265988
Title Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib (MERIDIAN)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Alfredo Berruti
Indications

prostate carcinoma

Therapies

Cabozantinib

Age Groups: adult | senior | child
Covered Countries ITA


No variant requirements are available.